Table 2. Univariate and multivariate COX regression analysis for overall survival in DLBCL patients.
Overall Survival | ||||
---|---|---|---|---|
Univariate COX Regression | Multivariate COX Regression | |||
HR (IC 95%) | P | HR (IC 95%) | P | |
CXCR7 (+ vs -) | 2.668 (1.080–6.592) | 0.033 * | 2.764 (1.077–7.093) | 0.035 * |
ECOG (0–2 vs >2) | 2.927 (1.112–7.706) | 0.030 * | 2.756 (1.020–7.448) | 0.046 * |
IPI (0–2 vs 3–5) | 2.773 (1.072–7.173) | 0.035 * | 2.910 (1.099–7.709) | 0.032 * |
Stage (I-II vs III-IV) | 1.896 (0.711–5.052) | 0.201 | ||
LDH (normal vs high) | 1.004 (0.408–2.472) | 0.994 | ||
BM (+ vs -) | 1.814 (0.653–5.043) | 0.254 | ||
GCB (yes vs no) | 2.094 (0.645–6.805) | 0.219 | ||
Age (< 60 vs ≥ 60) | 1.010 (0.410–2.487) | 0.982 |
Only factors identified as significant in the univariate analysis were included in the multivariate analysis. HR, hazard ratio; 95% IC, 95% confidence interval of hazard ratio; ECOG, Eastern Cooperative Group; LDH, lactate dehydrogenase; IPI, International Prognostic Index; BM, bone marrow; GCB, germinal center B-cell like.
*P ≤ 0.05